Cargando…
Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
OBJECTIVE: To assess whether corticosteroids are associated with increased risk of gastrointestinal bleeding or perforation. DESIGN: Systematic review and meta-analysis of randomised, double-blind, controlled trials comparing a corticosteroid to placebo for any medical condition or in healthy partic...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025450/ https://www.ncbi.nlm.nih.gov/pubmed/24833682 http://dx.doi.org/10.1136/bmjopen-2013-004587 |
_version_ | 1782316761877577728 |
---|---|
author | Narum, Sigrid Westergren, Tone Klemp, Marianne |
author_facet | Narum, Sigrid Westergren, Tone Klemp, Marianne |
author_sort | Narum, Sigrid |
collection | PubMed |
description | OBJECTIVE: To assess whether corticosteroids are associated with increased risk of gastrointestinal bleeding or perforation. DESIGN: Systematic review and meta-analysis of randomised, double-blind, controlled trials comparing a corticosteroid to placebo for any medical condition or in healthy participants. Studies with steroids given either locally, as a single dose, or in crossover studies were excluded. DATA SOURCES: Literature search using MEDLINE, EMBASE and Cochrane Database of Systematic Reviews between 1983 and 22 May 2013. OUTCOME MEASURE: Outcome measures were the occurrence of gastrointestinal bleeding or perforation. Predefined subgroup analyses were carried out for disease severity, use of non-steroidal anti-inflammatory drugs (NSAIDs) or gastroprotective drugs, and history of peptic ulcer. RESULTS: 159 studies (N=33 253) were included. In total, 804 (2.4%) patients had a gastrointestinal bleeding or perforation (2.9% and 2.0% for corticosteroids and placebo). Corticosteroids increased the risk of gastrointestinal bleeding or perforation by 40% (OR 1.43, 95% CI 1.22 to 1.66). The risk was increased for hospitalised patients (OR 1.42, 95% CI 1.22 to 1.66). For patients in ambulatory care, the increased risk was not statistically significant (OR 1.63, 95% CI 0.42 to 6.34). Only 11 gastrointestinal bleeds or perforations occurred among 8651 patients in ambulatory care (0.13%). Increased risk was still present in subgroup analyses (studies with NSAID use excluded; OR 1.44, 95% CI 1.20 to 1.71, peptic ulcer as an exclusion criterion excluded; OR 1.47, 95% CI 1.21 to 1.78, and use of gastroprotective drugs excluded; OR 1.42, 95% CI 1.21 to 1.67). CONCLUSIONS: Corticosteroid use was associated with increased risk of gastrointestinal bleeding and perforation. The increased risk was statistically significant for hospitalised patients only. For patients in ambulatory care, the total occurrence of bleeding or perforation was very low, and the increased risk was not statistically significant. |
format | Online Article Text |
id | pubmed-4025450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40254502014-05-21 Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis Narum, Sigrid Westergren, Tone Klemp, Marianne BMJ Open Gastroenterology and Hepatology OBJECTIVE: To assess whether corticosteroids are associated with increased risk of gastrointestinal bleeding or perforation. DESIGN: Systematic review and meta-analysis of randomised, double-blind, controlled trials comparing a corticosteroid to placebo for any medical condition or in healthy participants. Studies with steroids given either locally, as a single dose, or in crossover studies were excluded. DATA SOURCES: Literature search using MEDLINE, EMBASE and Cochrane Database of Systematic Reviews between 1983 and 22 May 2013. OUTCOME MEASURE: Outcome measures were the occurrence of gastrointestinal bleeding or perforation. Predefined subgroup analyses were carried out for disease severity, use of non-steroidal anti-inflammatory drugs (NSAIDs) or gastroprotective drugs, and history of peptic ulcer. RESULTS: 159 studies (N=33 253) were included. In total, 804 (2.4%) patients had a gastrointestinal bleeding or perforation (2.9% and 2.0% for corticosteroids and placebo). Corticosteroids increased the risk of gastrointestinal bleeding or perforation by 40% (OR 1.43, 95% CI 1.22 to 1.66). The risk was increased for hospitalised patients (OR 1.42, 95% CI 1.22 to 1.66). For patients in ambulatory care, the increased risk was not statistically significant (OR 1.63, 95% CI 0.42 to 6.34). Only 11 gastrointestinal bleeds or perforations occurred among 8651 patients in ambulatory care (0.13%). Increased risk was still present in subgroup analyses (studies with NSAID use excluded; OR 1.44, 95% CI 1.20 to 1.71, peptic ulcer as an exclusion criterion excluded; OR 1.47, 95% CI 1.21 to 1.78, and use of gastroprotective drugs excluded; OR 1.42, 95% CI 1.21 to 1.67). CONCLUSIONS: Corticosteroid use was associated with increased risk of gastrointestinal bleeding and perforation. The increased risk was statistically significant for hospitalised patients only. For patients in ambulatory care, the total occurrence of bleeding or perforation was very low, and the increased risk was not statistically significant. BMJ Publishing Group 2014-05-15 /pmc/articles/PMC4025450/ /pubmed/24833682 http://dx.doi.org/10.1136/bmjopen-2013-004587 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Gastroenterology and Hepatology Narum, Sigrid Westergren, Tone Klemp, Marianne Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis |
title | Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis |
title_full | Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis |
title_fullStr | Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis |
title_full_unstemmed | Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis |
title_short | Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis |
title_sort | corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis |
topic | Gastroenterology and Hepatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025450/ https://www.ncbi.nlm.nih.gov/pubmed/24833682 http://dx.doi.org/10.1136/bmjopen-2013-004587 |
work_keys_str_mv | AT narumsigrid corticosteroidsandriskofgastrointestinalbleedingasystematicreviewandmetaanalysis AT westergrentone corticosteroidsandriskofgastrointestinalbleedingasystematicreviewandmetaanalysis AT klempmarianne corticosteroidsandriskofgastrointestinalbleedingasystematicreviewandmetaanalysis |